<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>17(11)</volume><submitter>de Villiers de la Noue H</submitter><pubmed_abstract>&lt;i>Acinetobacter baumannii&lt;/i> is a critical public health threat, particularly with the rise in multidrug-resistant (MDR) and extensively drug-resistant (XDR) strains that limit treatment options. Phage therapy, which uses bacteriophages to target bacteria, offers a promising alternative. We isolated an XDR strain (Ab125) from a burn wound infection and screened 34 phages, identifying vB_AbaM_3098 as the only effective candidate. However, resistance rapidly emerged, producing a derivative strain (Ab139). Interestingly, Ab139, though resistant to vB_AbaM_3098, became susceptible to six previously inactive phages. While various potential determinants were identified through comparative genomics and proteomics, the mechanism causing phage resistance to vB_AbaM_3098 and simultaneous susceptib</pubmed_abstract><journal>Viruses</journal><pagination>1441</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12656882</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Rational Design of a Potent Two-Phage Cocktail Against a Contemporary &amp;lt;i&amp;gt;Acinetobacter baumannii&amp;lt;/i&amp;gt; Strain Recovered from a Burned Patient at the Lausanne University Hospital.</pubmed_title><pmcid>PMC12656882</pmcid><pubmed_authors>de Villiers de la Noue H</pubmed_authors><pubmed_authors>Vuattoux X</pubmed_authors><pubmed_authors>Resch G</pubmed_authors><pubmed_authors>Golliard G</pubmed_authors></additional><is_claimable>false</is_claimable><name>Rational Design of a Potent Two-Phage Cocktail Against a Contemporary &amp;lt;i&amp;gt;Acinetobacter baumannii&amp;lt;/i&amp;gt; Strain Recovered from a Burned Patient at the Lausanne University Hospital.</name><description>&lt;i>Acinetobacter baumannii&lt;/i> is a critical public health threat, particularly with the rise in multidrug-resistant (MDR) and extensively drug-resistant (XDR) strains that limit treatment options. Phage therapy, which uses bacteriophages to target bacteria, offers a promising alternative. We isolated an XDR strain (Ab125) from a burn wound infection and screened 34 phages, identifying vB_AbaM_3098 as the only effective candidate. However, resistance rapidly emerged, producing a derivative strain (Ab139). Interestingly, Ab139, though resistant to vB_AbaM_3098, became susceptible to six previously inactive phages. While various potential determinants were identified through comparative genomics and proteomics, the mechanism causing phage resistance to vB_AbaM_3098 and simultaneous susceptib</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Oct</publication><modification>2026-07-05T03:16:37.366Z</modification><creation>2026-07-05T03:08:18.152Z</creation></dates><accession>S-EPMC12656882</accession><cross_references><pubmed>41305464</pubmed><doi>10.3390/v17111441</doi></cross_references></HashMap>